Xarelto Alternatives Compared
| Xarelto (rivaroxaban) | Semaglutide | Wegovy (semaglutide) |
|
|---|
| Xarelto (rivaroxaban) | Semaglutide | Wegovy (semaglutide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Xarelto (rivaroxaban) is an oral anticoagulant used to treat deep vein thrombosis and pulmonary embolism, and for preventing blood clots and reducing cardiovascular risks across multiple conditions... View more |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction, Nonalcoholic Steatohepatitis. Wegovy may also be used for purposes not listed in this medication guide. |
Related suggestions Cardiovascular Risk Reduction
|
|||||||
| More about Xarelto (rivaroxaban) | More about Semaglutide | More about Wegovy (semaglutide) | ||||||||
| Ratings & Reviews | ||||||||||
|
Xarelto has an average rating of 5.4 out of 10 from a total of 228 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 42% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2769 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
Wegovy has an average rating of 7.6 out of 10 from a total of 527 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Xarelto side effects |
View all Semaglutide side effects |
View all Wegovy side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
View all Xarelto prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
||||||||
| Brand Names | ||||||||||
|
N/A |
Ozempic, Rybelsus, Wegovy | Other semaglutide brands include: Ozempic, Rybelsus | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
13 hours |
168 hours |
168 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 391 drugs are known to interact with Xarelto:
|
A total of 275 drugs are known to interact with Semaglutide:
|
A total of 275 drugs are known to interact with Wegovy:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
N/A |
December 05, 2017 |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
|
||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.